For research use only ยท Not for human or animal consumption
// Neuropeptide & Melanocortin

Melanotan-2 Research Guide

A cyclic, non-selective melanocortin receptor agonist that is investigational and not approved. Covers the 1990s pilot studies and the safety literature.

5Sources
3FAQs
4Min read
For research use only. Not for human consumption.
01

What is Melanotan-2?

Melanotan-2 (MT-II) is a synthetic, lactam-bridged cyclic heptapeptide analogue of ฮฑ-MSH, with the structure Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to ฮฑ-MSH 4 to 10 (Dorr et al., 1996).

MT-II is a non-selective melanocortin receptor agonist (Wessells et al., 2000) with very potent melanotropic activity in vitro (Dorr et al., 1996). Unlike Melanotan-1, it has never been approved as a medicine.

02

Research areas studied

The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.

Early human pilot study

A 1996 single-blind pilot phase I study in 3 healthy men reported increased skin pigmentation one week after the last injection. It also reported mild nausea, somnolence and fatigue, and a stretching and yawning complex that coincided with spontaneous erections (Dorr et al., 1996).

Small controlled studies

Double-blind, placebo-controlled crossover studies in men with erectile dysfunction, first in 10 men with psychogenic erectile dysfunction (Wessells et al., 1998) and then in 20 men with psychogenic or organic erectile dysfunction (Wessells et al., 2000), reported erections after MT-II. Nausea and yawning were frequent side effects, and severe nausea was reported in some participants (Wessells et al., 2000).

Safety literature

A 2017 dermatology review describes melanotan I and II as untested, unregulated analogues used mainly for tanning. It cites increasing case reports of changes in existing moles and new dysplastic nevi, and four case reports of melanoma arising from existing moles during or shortly after melanotan use, while noting that conclusive evidence linking them is lacking. Multiple national health organizations have issued safety warnings (Habbema et al., 2017).

Regulatory status

MT-II is not an approved drug. FDA’s compounding safety page lists Melanotan II among nominated substances whose nominations were withdrawn and cites published case reports of serious adverse events, including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism. Bremelanotide is a different ฮฑ-MSH analogue with its own approval, which does not cover MT-II. Controlled human data are limited to small studies from the 1990s.

03

Storage and handling

Like most research peptides, Melanotan-2 is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.

When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.

04

Quality and COA

Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.

05

Melanotan-2 FAQ

What is the structure of Melanotan-2?

It is a lactam-bridged cyclic heptapeptide: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, an analogue of ฮฑ-MSH 4 to 10.

Is Melanotan-2 approved anywhere?

No. It is an investigational compound, and FDA lists Melanotan II among bulk substances whose compounding nominations were withdrawn.

How is Melanotan-2 different from Melanotan-1?

Melanotan-2 is a cyclic peptide that acts at several melanocortin receptors. Melanotan-1 (afamelanotide) is a linear analogue that acts at MC1R and is approved as an implant for one rare disorder.

07

References

  1. Dorr RT, Lines R, Levine N, et al. (1996). Life Sci. PubMed 8637402
  2. Wessells H, Levine N, Hadley ME, et al. (2000). Int J Impot Res. PubMed 11035391
  3. Wessells H, Fuciarelli K, Hansen J, et al. (1998). J Urol. PubMed 9679884
  4. Habbema L, Halk AB, Neumann M, et al. (2017). Int J Dermatol. PubMed 28266027
  5. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov

For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.

Get 15% Off Your First Order

Join the Zero Zero Collection list for restock alerts, new COAs and member pricing. Research use only.